1.39
Akoya Biosciences Inc (AKYA) 最新ニュース
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 30.8% in March - Defense World
Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges By Investing.com - Investing.com South Africa
Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges - Investing.com
This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Akoya Biosciences’ (AKYA) Equal Weight Rating Reaffirmed at Stephens - Defense World
Akoya Biosciences Shares Fall After Downgrade From Stephens - MarketScreener
Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Stephens Downgrades Akoya Biosciences to Equalweight From Overweight, Price Target is $1.80 - Marketscreener.com
Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia
Tikvah to oppose Quanterix-Akoya Biosciences merger - Investing.com India
Tikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya Biosciences - Business Wire
Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Marketscreener.com
Key Investor Fights Back: Quanterix Merger Under Fire Over Valuation Concerns - Stock Titan
Akoya Biosciences (AKYA) to Release Quarterly Earnings on Monday - Defense World
Akoya Biosciences Reports 2024 Financial Results - TipRanks
Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates - MSN
Akoya Biosciences (NASDAQ:AKYA) Receives Overweight Rating from Stephens - Defense World
Akoya Biosciences Shares Down 6.4% After Stock Offering… -June 08, 2023 at 10:10 am EDT - Marketscreener.com
Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges By Investing.com - Investing.com South Africa
Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges - Investing.com Australia
Akoya: Q4 Earnings Snapshot - Milford Mirror
Akoya Biosciences earnings missed by $0.01, revenue topped estimates - Investing.com Australia
Akoya Biosciences, Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq
Akoya Biosciences, Inc. SEC 10-K Report - TradingView
Kent Lake urges Quanterix to address questions regarding Akoya deal -March 17, 2025 at 04:28 pm EDT - Marketscreener.com
Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Amid Pending Acquisition by Quanterix Corporation - Nasdaq
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - GlobeNewswire
Quanterix Merger Under Fire: Top Investor Reveals Shocking 82% Value Disparity - Stock Titan
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call - Bluefield Daily Telegraph
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Brokerages - Defense World
Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger -March 11, 2025 at 10:40 am EDT - Marketscreener.com
Quanterix Merger Under Fire: 7.25% Stakeholder Reveals Shocking Valuation Concerns - StockTitan
Akoya climbs after merger deal with Quanterix - MSN
Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3 - Marketscreener.com
Piper Sandler cuts Akoya Biosciences stock rating to Neutral - Investing.com
Piper Sandler cuts Akoya Biosciences stock rating to Neutral By Investing.com - Investing.com Canada
Quanterix Announces Acquisition of Akoya Biosciences - TipRanks
Quanterix Highlights Benefits Of Akoya Biosciences Acquisition -March 03, 2025 at 06:13 am EST - Marketscreener.com
Can Quanterix's Akoya Acquisition Transform Biomarker Detection and Deliver $1B Revenue? - StockTitan
Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition - Bluefield Daily Telegraph
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 60.1% in February - Defense World
Akoya Biosciences (AKYA) to Release Earnings on Monday - MarketBeat
Akoya Biosciences’ Merger with Quanterix Moves Forward - Investing.com India
Quanterix advances towards Akoya Biosciences acquisition By Investing.com - Investing.com Australia
Akoya Biosciences' Merger with Quanterix Moves Forward By Investing.com - Investing.com South Africa
Quanterix advances towards Akoya Biosciences acquisition - Investing.com
Akoya Biosciences’ Merger with Quanterix Moves Forward By Investing.com - Investing.com UK
Akoya Biosciences stock hits 52-week low at $1.88 amid market challenges - Investing.com Australia
大文字化:
|
ボリューム (24 時間):